๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

27 recruiting trials

for Pediatric Osteosarcoma

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors NCT02508038Phase 11 site๐Ÿ“ Madison University of Wisconsin, Madison ยท Tests: TCRฮฑฮฒ+/CD19+ depleted Haploidentical HSCT, Zoledronate Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma NCT06796543NA3 sites๐Ÿ“ Washington D.C.๐Ÿ“ Baltimore๐Ÿ“ Minneapolis Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: Consolidative radiation therapy (cRT) Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas NCT07222735Phase 11 site๐Ÿ“ Memphis St. Jude Children's Research Hospital ยท Tests: Fludarabine, Cyclophosphamide, B7-H3-CAR T Cells, Radiation Therapy Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma NCT07144254Phase 12 sites๐Ÿ“ Atlanta๐Ÿ“ Houston Emory University ยท Tests: Tegavivint, Gemcitabine Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse NCT07871864Phase 377 sites๐Ÿ“ Aarhus๐Ÿ“ Aarhus๐Ÿ“ Copenhagen Gustave Roussy, Cancer Campus, Grand Paris ยท Tests: Experimental group : Cabometyx ยฎ 40mg/m2/day (Max: 60mg/day) , Treatment schedule : Daily**, day 1-28 during 4 weeks (iโ€ฆ Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision) NCT06094101Phase 1, Phase 24 sites๐Ÿ“ Essen๐Ÿ“ Frankfurt am Main๐Ÿ“ Freiburg im Breisgau University Hospital Tuebingen ยท Tests: Peptide vaccine IPX A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors NCT05135975Phase 26 sites๐Ÿ“ Birmingham๐Ÿ“ Aurora๐Ÿ“ Washington D.C. Nationwide Children's Hospital ยท Tests: Cabozantinib Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors NCT02013336Phase 15 sites๐Ÿ“ Cincinnati๐Ÿ“ Oklahoma City๐Ÿ“ Dallas South Plains Oncology Consortium ยท Tests: MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide SPEARHEAD-3 Pediatric Study NCT05642455Phase 1, Phase 210 sites๐Ÿ“ Palo Alto๐Ÿ“ Bethesda๐Ÿ“ Boston USWM CT, LLC ยท Tests: Afamitresgene autoleucel Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors NCT06625190Phase 1, Phase 21 site๐Ÿ“ Gainesville University of Florida ยท Tests: Miltenyi CliniMACS Prodigy ยฎ system, Zoledronic acid Losartan + Sunitinib in Treatment of Osteosarcoma NCT03900793Phase 14 sites๐Ÿ“ Los Angeles๐Ÿ“ Aurora๐Ÿ“ Aurora University of Colorado, Denver ยท Tests: Losartan, Sunitinib Biomarkers of Resiliency In Childhood Cancer Surgery NCT06674811n/a1 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Wearing Smartwatch, Patient Report Outcomes, Blood Draw, Clinical Data Review Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma NCT05734066Phase 1, Phase 215 sites๐Ÿ“ Los Angeles๐Ÿ“ Palo Alto๐Ÿ“ Washington D.C. Jazz Pharmaceuticals ยท Tests: Lurbinectedin A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patients With Advanced High-Grade Osteosarcoma NCT06650514Phase 21 site๐Ÿ“ Barcelona Vall d'Hebron Institute of Oncology ยท Tests: OMO-103 The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma NCT07560826Phase 29 sites๐Ÿ“ Chapel Hill๐Ÿ“ Charlotte๐Ÿ“ Charlotte Wake Forest University Health Sciences ยท Tests: High-dose Methotrexate Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma NCT03721068Phase 12 sites๐Ÿ“ Atlanta๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: iC9.GD2.CAR.IL-15 T-cells, Cyclophosphamide, Fludarabine Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma NCT04901702Phase 1, Phase 210 sites๐Ÿ“ Palo Alto๐Ÿ“ Aurora๐Ÿ“ Washington D.C. St. Jude Children's Research Hospital ยท Tests: Onivyde, Talazoparib, Temozolomide Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma NCT07428993Phase 21 site๐Ÿ“ Memphis St. Jude Children's Research Hospital ยท Tests: Cyclophosphamide, Fludarabine, Mesna, Apheresis, SJCARB7H3_41BBL infusion Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients NCT07502885n/a1 site๐Ÿ“ Memphis St. Jude Children's Research Hospital ยท Tests: Lab based 3D Gait Assessment, Wearable Inertial Sensors (In Lab and Remote), Functional Testing & Patient Reported โ€ฆ Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01) NCT06395103Phase 1, Phase 271 sites๐Ÿ“ Los Angeles๐Ÿ“ Aurora๐Ÿ“ New Haven Merck Sharp & Dohme LLC ยท Tests: Zilovertamab vedotin B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) NCT04897321Phase 11 site๐Ÿ“ Memphis St. Jude Children's Research Hospital ยท Tests: Fludarabine, Cyclophosphamide, MESNA, B7-H3 CAR T cells Pediatric PET/MR Image Registry NCT03458520n/a1 site๐Ÿ“ Palo Alto Stanford University ยท Tests: PET/MR imaging, MR imaging, PET/CT imaging Tissue Expression of Krรผppel-Like Factors 4 and 7 in Bone Tumors NCT06935864n/a2 sites๐Ÿ“ Cairo๐Ÿ“ Cairo Ain Shams University ยท Tests: KLF factor (4 and 7) Lurbinectedin in FET-Fused Tumors NCT05918640Phase 1, Phase 26 sites๐Ÿ“ Los Angeles๐Ÿ“ Iowa City๐Ÿ“ Boston Children's Hospital of Philadelphia ยท Tests: Lurbinectedin Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS) NCT07297979Phase 113 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Baltimore Amgen ยท Tests: Xaluritamig Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma NCT07514819NA1 site๐Ÿ“ Memphis St. Jude Children's Research Hospital ยท Tests: Proton Therapy (Adaptive) Molecular Analysis Of Solid Tumors NCT01050296n/a1 site๐Ÿ“ Memphis St. Jude Children's Research Hospital
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy